UBS Group »

Madrigal Pharmaceuticals shares owned by UBS Group

Quarter-by-quarter ownership of Madrigal Pharmaceuticals (MDGL) shares owned by UBS Group from 13F filings

Historical chart of UBS Group investment in Madrigal Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Madrigal Pharmaceuticals held by UBS Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Madrigal Pharmaceuticals by UBS Group

Quarter filed Position value Share count Share price at filing
2024-03-31 $34M 125k 267.04
2023-12-31 $20M 88k 231.38
2023-09-30 $8.2M 56k 146.04
2023-06-30 $5.4M 23k 231.00
2023-03-31 $7.5M 31k 242.26
2022-12-31 $28M 97k 290.25
2022-09-30 $1.7M 26k 65.00
2022-06-30 $1.3M 18k 71.60
2022-03-31 $2.9M 30k 97.79
2021-12-31 $1.9M 22k 84.70
2021-09-30 $1.7M 22k 79.84
2021-06-30 $592k 6.1k 97.33
2021-03-31 $1.9M 17k 116.99
2020-12-31 $267k 2.4k 110.97
2020-09-30 $304k 2.6k 118.76
2020-06-30 $282k 2.5k 113.47
2020-03-31 $640k 9.6k 66.75
2019-12-31 $100k 1.1k 92.92
2019-09-30 $2.1M 25k 86.24
2019-06-30 $1.2M 11k 104.84
2019-03-31 $1.2M 9.6k 125.00
2018-12-31 $669k 5.9k 112.76
2018-09-30 $1.6M 7.6k 214.15
2018-06-30 $2.5M 8.8k 279.63
2018-03-31 $4.5M 39k 116.75
2017-12-31 $17k 187 90.91
2017-09-30 $46k 1.0k 44.62
2017-03-31 $29k 1.9k 15.59
2016-12-31 $14k 967 14.55
2016-09-30 $2.0k 142 14.08